Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

TAKE-TWO INTERACTIVE SOFTWARE, INC Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $201.13 (market cap $37.46B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 20.8× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 111 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TTWOVIR
Market Cap
$37.46B$1.80B
Volume
5,201,6701,782,836
Sector
TechnologyHealth
52-Week High
$262.29$11.78
52-Week Low
$189.69$5.12
Typical Hold Time
111 Days0 Days
Enterprise Value
$38.57B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Take-Two Interactive (TTWO) trades at $201.23, down 3.63% today amid mixed technical signals and volatile earnings performance. The stock shows strong analyst support with 79% buy ratings and a $292.30 consensus price target, representing 45% upside potential. Recent quarterly results have been inconsistent with two beats and one miss, while the company maintains anticipation for Grand Theft Auto VI's November 2026 launch. Fundamentals reveal significant losses with a -79.51% net margin in 2025, though revenue growth continues and cash position remains strong at $1.47 billion.

The investment case hinges on GTA VI's successful execution, with current valuation reflecting high expectations. While analyst optimism remains strong, investors face risks from execution missteps, competitive pressures, and the stock's premium valuation multiples. The substantial negative earnings and cash flow volatility require careful monitoring, though institutional ownership trends show continued confidence in the long-term gaming franchise strategy.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TTWO
89% Buy11% Sell
Avg holding period · 111 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.

Read more on TTWO →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →